Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Permethrin vs Sulfur for Scabies
NCT05862701Phase 1Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- Mar 2022
- Primary completion
- Sep 2022
- Modality
- Nanoparticles, Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of permethrin and sulfur ointment in scabies, sponsored by Combined Military Hospital Abbottabad. Primary endpoints: Symptomatic Improvement at 4 weeks and No new lesions formation at 4 weeks. Started Mar 2022; status: completed.
02
Drugs
permethrinsulfur ointment
03
Conditions
scabies
Beyond the preview
Go deeper on NCT05862701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05862701.